{"retracted":false,"update":{"timestamp":1102982400000,"doi":"10.1073/pnas.0404694101","type":"correction"},"doi":"10.1073/pnas.0402653101","journal":"Proceedings of the National Academy of Sciences","publisher":"Proceedings of the National Academy of Sciences","title":"Correction for Bielekova et al., Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon Â , PNAS 2004 101:8705-8708"}
